Aarti Industries Ltd · NSE:AARTIIND

Aarti Industries — Q1 FY21 Earnings Presentation

15 slides from Aarti Industries's earnings presentation, Aug 13, 2020

  1. Slide 1: Cover letter to stock exchanges

    ® AARTI INDUSTRIES LIMITED Ref. No.: AIL/B-40/2020/126 August 13, 2020 To, To, Listing/Compliance Department Listing/Compliance Department BSE LTD. National Stock Exchange of Phiroze Jeejeebhoy Towers, India Limited Dalal Street, “Exchange Plaza”, Plot No. C/1, Mumbai — 400 001. G Block Bandra-Kurla

  2. Slide 2: Q1 FY21 Results Presentation

    AARTI INDUSTRIES LIMITED Q1 FY21 Results Presentation August 2020

  3. Slide 3: Disclaimer

    Disclaimer AARTI INDUSTRIES LIMITED may, from time to time, make written and oral forward looking statements, in addition to statements contained in the company's filings with BSE Limited [BSE] and National Stock Exchange of India Limited [NSE], and our reports to shareholders. The company does not

  4. Slide 4: Agenda

    Agenda 1 | At a glance 2 | Quarterly and Annual performance 3

  5. Slide 5: Company Overview

    Company Overview Overview Key Metrics  A leading Speciality Chemicals company in Benzene based derivatives with integrated operations and high level of cost optimization 200+ 400+ 700+ Global Domestic  Established by first generation technocrats in 1984 Products Customers Customers  Pharma operat

  6. Slide 6: Key Strengths

    Key Strengths • Global Player in Benzene based Derivatives with Integrated Operations o Strong/Leadership position in key products and processes o Integrated operations across product chain of Benzene and Toluene o Ability to effectively use co-products and generate value-added products • Well Diver

  7. Slide 7: Agenda

    Agenda 1 | At a glance 2 | Quarterly & Annual performance 6

  8. Slide 8: Chairman's Message

    Chairman’s Message Commenting on the performance for Q1 FY21, Mr. Rajendra Gogri – Chairman & MD at Aarti Industries Limited said, “Q1 performance was largely in line with our expectations and the outlook shared previously. During the quarter, due to the restrictions enforced during lockdown, our Sp

  9. Slide 9: Q1 FY21 P&L (Consolidated)

    Q1 FY21 P&L (Consolidated) Particulars Y-o-Y Q1 FY21 Q1 FY20 Q4 FY20  Revenue and EBIDTA impacted due to (Rs. Crore) (%) weakness in some usage verticals on Gross Income from Operations 1,035 1,135 -8.8% 1,190 account of COVID-19 Exports 487 488 -0.2% 482  Higher inventory in various products due

  10. Slide 10: Q1 FY21 – Speciality Chemicals (Consolidated)

    Q1 FY21 – Speciality Chemicals (Consolidated) Revenue 944 841  COVID-19 and lockdown resulted in lower sales, loss of production days, higher inventory, etc.  Operations in April were at 50% due to Q1 FY20 Q1 FY21 lockdown  Higher expenses upon commercialization of EBIT units in Q4FY20 213  Prov

  11. Slide 11: Q1 FY21 – Pharma (Consolidated)

    Q1 FY21 – Pharma (Consolidated) Revenue 191 194  Pharma business revenue grew by 1.6% YoY in Q1  A new high in quarterly profits in the pharma segment for the company  EBIT margins have seen significant Q1 FY20 Q1 FY21 expansion based on higher contribution from regulated markets and value- added

  12. Slide 12: Revenue Performance (Consolidated)

    Revenue Performance (Consolidated) Revenue Export Deep engagement with Operating revenues have grown on the back of global customers in CAGR: 11% strong volume growth in 1,977 1,966 Speciality Chemicals and key business segments and 1,523 1,596 Pharma. In addition, some 1,431 4,705 4,621 part of dom

  13. Slide 13: EBIT Performance (Consolidated)

    EBIT Performance (Consolidated) EBIT Higher growth relative to revenue CAGR: 15% highlights value addition 932 952 delivered by AIL 663 615 542 175 FY16 FY17 FY18 FY19 FY20 Q1 FY21 Speciality Chemicals Pharmacuticals CAGR: 13% CAGR: 37% 137 819 814 113 566 581 504 79 39 48 45 130 FY16 FY17 FY18 FY19

  14. Slide 14: Contact Us

    Contact Us For further information please log on to www.aarti-industries.com or contact: Mr. Chetan Gandhi / Mr. Raj Sarraf Aarti Industries Limited Tel: +91 22 6797 6666 Email: info@aarti-industries.com Shiv Muttoo / Shruti Joshi CDR India Tel: +91 98335 57572 / +91 75065 67349 Email: shiv@cdr-indi

  15. Slide 15: Thank You

    | PRODUCTIVE [WITH SAF [Sear TL ART SA

Aarti Industries — Q1 FY21 Earnings Presentation on 6ix